Clinical Trial Update: Carbidopa-Levodopa in Dry AMD With Geographic Atrophy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating carbidopa-levodopa for dry age-related macular degeneration was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• carbidopa-levodopa (carbidopa-levodopa)

Snippet

Sponsor: Snyder, Robert W., M.D., Ph.D., P.C. | Conditions: Age Related Macular Degeneration | Phase 2 | Status: TERMINATED